April 21, 2026 STAT+: At AACR, more strong results for Revolution Medicine’s KRAS drug, plus assurance from NCI’s director April 21, 2026 STAT+: Kyverna Therapeutics plans to submit cell therapy for stiff person syndrome for FDA approval April 21, 2026 STAT+: From Revolution Medicines, more strong data on KRAS drug and a glimpse of a ‘novel class’ beyond it April 21, 2026 STAT+: With successful trials, Roche takes its MS drug to regulators, but safety questions loom April 21, 2026 Judge postpones OxyContin-maker Purdue Pharma’s sentencing to let opioid victims attend in person April 21, 2026 STAT+: Insurers refuse to join Medicare pilot offering weight loss drugs to seniors at steep discount April 21, 2026 STAT+: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS April 21, 2026 STAT+: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS April 21, 2026 STAT+: CMS to ask every state for new audits of health care providers April 21, 2026 Opinion: STAT+: I’m an expert on presidential health. The 25th Amendment is not an option for removing Trump April 21, 2026 STAT+: RFK Jr. to face four GOP doctors at Senate hearings April 21, 2026 STAT+: UnitedHealth earnings beat expectations in the first quarter, but hurdles persist April 21, 2026 Flu vaccine no longer mandated for U.S. troops, defense secretary says April 21, 2026 QuikTrip to sell urgent care clinics after 6 years in business April 21, 2026 Providers push back on 340B rebate model April 21, 2026 Blue Shield of California taps chief pharmacy officer April 21, 2026 UnitedHealth hikes profit outlook after better-than-expected first quarter April 21, 2026 UnitedHealth Reports Strong Quarterly Turnaround, Raises Full-Year Outlook April 21, 2026 STAT+: Pharmalittle: We’re reading about a Purdue Pharma settlement, a setback for Merck and Eisai, and more April 21, 2026 STAT+: Kelonia Therapeutics’ road from floundering to $3 billion April 21, 2026 This CDC conference was always open to the public. Until now April 21, 2026 STAT+: Kennedy hints at coming breakthrough device announcement April 21, 2026 STAT+: BioAge says experimental pill aimed at reducing heart risks significantly reduced inflammation April 21, 2026 STAT+: Tortugas Neuroscience launches with hopes to develop drugs for brain disorders, other conditions April 21, 2026 Opinion: What happens when a chief executive loses executive functions? April 21, 2026 Opinion: The U.S. health care system is built around looking backward April 20, 2026 Trump Orders New Tariffs on Imported Drugs, Escalating Push to Bring Pharmaceutical Manufacturing Back to the U.S. April 20, 2026 STAT+: At AACR, a provocative use of CAR-T, Merck’s new thing and cancer’s geography problem April 20, 2026 STAT+: Former banker brought on to revitalize Pfizer’s strategy departs his post April 20, 2026 STAT+: In early trial, CAR-T results raise hope of preventing multiple myeloma in high-risk patients April 20, 2026 Opinion: The contradiction at the heart of Republicans’ embrace of psychedelics April 20, 2026 STAT+: Trump order to advance psychedelic treatments generates excitement — and worries April 20, 2026 Judge dismisses Aetna’s No Surprises fraud suit against Radiology Partners April 20, 2026 STAT+: Eli Lilly’s $3.25 billion acquisition of Kelonia Therapeutics caps startup’s tortuous ride April 20, 2026 Physician burnout is improving but some specialties lag, the AMA finds April 20, 2026 STAT+: The PBMs fight back, and arbitration doesn’t lose April 20, 2026 RFK Jr. defends HHS tenure, 12% proposed budget cut April 20, 2026 STAT+: Finally cracking KRAS as a druggable target April 20, 2026 GE HealthCare, RadNet expand AI mammography collaboration April 20, 2026 STAT+: Pharmalittle: We’re reading about Trump boosting psychedelic treatment, the future for weight-loss drugs, and more Previous Page 1 … 30 31 32 33 34 … 40 Next Page 2026-03-30
